D
Cardiff Oncology, Inc. CRDF
$4.00 $0.051.27%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -3.21% 17.02% 50.93% 146.99% 21.88%
Total Other Revenue -- -- -- -- --
Total Revenue -3.21% 17.02% 50.93% 146.99% 21.88%
Cost of Revenue 25.11% 20.17% 18.37% -11.53% 20.51%
Gross Profit -25.69% -20.23% -17.92% 13.00% -20.48%
SG&A Expenses 10.50% 6.36% -25.16% 1.52% -11.47%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 21.31% 16.47% 3.18% -8.22% 10.17%
Operating Income -21.68% -16.46% -2.76% 9.28% -10.01%
Income Before Tax -26.24% -21.83% -5.63% 10.80% -7.36%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -26.24% -21.83% -5.63% 10.80% -7.36%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -26.24% -21.83% -5.63% 10.80% -7.36%
EBIT -21.68% -16.46% -2.76% 9.28% -10.01%
EBITDA -21.97% -16.68% -2.73% 9.45% -9.92%
EPS Basic -4.02% -16.15% -5.29% 10.78% -6.96%
Normalized Basic EPS -4.06% -16.16% -5.26% 10.83% -6.96%
EPS Diluted -4.02% -16.15% -5.29% 10.78% -6.96%
Normalized Diluted EPS -4.06% -16.16% -5.26% 10.83% -6.96%
Average Basic Shares Outstanding 21.35% 4.90% 0.33% 0.00% 0.34%
Average Diluted Shares Outstanding 21.35% 4.90% 0.33% 0.00% 0.34%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings